Recent Advances in the Synthesis, Functionalization and Applications of Pyrazole-Type Compounds I

• その他の著者: Silva, Vera L. M. (編集者), Silva, Artur M. S. (編集者)
• フォーマット: 電子媒体 図書の章
• 言語: 英語
• 出版事項: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• 主題: Research & information: general; Chemistry; Organic chemistry; pyrazolopyridopyridazine dione; N-aminopyrazolopyrrolopyridine dione; luminol; photoluminescence; pyrazole; coumarin; antimicrobial; hydrazone; biofilm; Staphylococcus aureus; S. epidermidis; MRSA; pyrazolyl-ureas; pyrazole nucleus; protein kinase inhibitors; anti-inflammatory agents; anticancer agents; anti-pathogens agents; nitrated pyrazoles-based; energetic salts; synthesis; high energy density material; insensitivity; amination; 4-halopyrazole; Buchwald-Hartwig coupling; Pd(dba)2; CuI mediated coupling; aliphatic amine; X-ray; pyrazolate; coinage metals; metallacycles; M06-2x; pyrazolyl-s-triazine; Fe(III); self-assembly; Hirshfeld; antimicrobial activity; pyrazoles; styrylpyrazoles; biological activity; organic synthesis; reactivity; homocoupling; bipyrazole; transition-metal catalysts; metal-organic frameworks; 1,3-dipolar cycloadditions; 2,3-dihydropyrazolo[1,2-a]pyrazoles; copper-catalyzed azomethine imine-alkyne cycloaddition (CuAIAC); azomethine imines; ynones; bis(pyrazol-1-yl)alkanes; carboxylation; oxalyl chloride; dicarboxylic acids; alkylation; superbasic medium; 1,2,4-oxadiazoles; spiropyrazolinium compounds; in vitro antitubercular screening; X-ray diffraction; molecular docking; polynuclear; silver; crystal structure; pyrazolate ligand; coordination polymer; functionalization; heterocyclic; neurodegeneration; Alzheimer's disease; Parkinson's disease; inhibitor; antagonist; antitumor scaffold; enzymatic inhibitory; N-heterocyclic compounds; pyrazolo[1,5-a]pyrimidine; pyrazolo[1,5-a]pyrimidines; aromatic substitution; electrooxidation; C-H halogenation; C-H thiocyanation; N-N coupling; cyclic voltammetry; n/a
• オンライン･アクセス: DOAB: download the publication; DOAB: description of the publication

Pyrazoles and their reduced form, pyrazolines, are considered privileged scaffolds in medicinal chemistry, owing to their noteworthy biological activities, physicochemical properties and occurrence in many low-molecular-weight compounds present in several marketed drugs (e.g., Celebrex® and Viagra®)...